Department of Pediatrics, University of Pennsylvania School of Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Thromb Res. 2010 Apr;125(4):292-6. doi: 10.1016/j.thromres.2009.11.023. Epub 2009 Dec 9.
Chemokines are a family of small proteins that have significant roles in inflammation, angiogenesis and cellular homing. Since inflammation and hemostasis/thrombosis have multiple overlapping roles and pathways, one could expect that some chemokines would also have biologically significant roles in hemostasis/thrombosis as well. This would especially be true for chemokines that are localized solely or predominantly within platelets and released in large amounts at sites of platelet activation such as platelet factor 4 (PF4, CXCL4) and its closely related chemokine, platelet basic protein (PBP, CXCL7). Our group and others have clearly demonstrated an in vivo role for PF4 in hemostasis/thrombosis, but not for PBP, which in contrast has clear proinflammatory properties. This review will focus on PF4 and its potential roles in hemostasis/thrombosis and the underlying pathways by which PF4 may be especially important in such pathologic thrombotic states as heparin-induced thrombocytopenia (HIT) and septic shock.
趋化因子是一类小蛋白,在炎症、血管生成和细胞归巢中具有重要作用。由于炎症和止血/血栓形成有多个重叠的作用和途径,人们可以预期某些趋化因子在止血/血栓形成中也具有重要的生物学作用。对于那些仅或主要定位于血小板内并在血小板激活部位大量释放的趋化因子,情况尤其如此,例如血小板因子 4 (PF4,CXCL4)及其密切相关的趋化因子血小板碱性蛋白 (PBP,CXCL7)。我们的研究小组和其他研究小组已经清楚地证明了 PF4 在止血/血栓形成中的体内作用,但 PBP 没有这种作用,相反,PBP 具有明显的促炎特性。这篇综述将重点介绍 PF4 及其在止血/血栓形成中的潜在作用,以及 PF4 可能在肝素诱导的血小板减少症 (HIT)和感染性休克等病理血栓形成状态中特别重要的潜在途径。